Innovation Articles

  1. Emerging Fields In Immunology: New Frontiers For Therapeutic Discovery 9/1/2026

    Immunology has expanded into several specialized domains as our understanding of the immune system has grown.

  2. Turning Pediatric Cancer Discoveries Into Medicines Requires Better Connections 8/27/2026

    Promising pediatric cancer science often stalls before patients benefit. David Adler explains how better connections could change that.

  3. From Cell State Reprogramming To The Clinic: Turning The Regulatory Genome Into RNA Medicines (Pt. 2) 8/26/2026

    Ounzain discusses how regulatory genome biology is being translated into drug discovery, from identifying lncRNA targets to building clinically relevant therapeutics and more.

  4. Novel Approach To Cancer Explores Severing Its Genetic Supply Line 8/25/2026

    Gene ablation represents an important and novel approach to treating cancer. One company is focusing on disabling the NRF2 gene to starve cancer cells.

  5. Drugging The tRNA Control System 8/19/2026

    Drug discovery has usually treated transfer RNA as cellular infrastructure: indispensable, highly conserved, and therefore dangerous to perturb. That description is accurate but incomplete. 

  6. Immune Reset In Rheumatology: Moving Beyond Disease Suppression Toward Durable Remission 8/18/2026

    EULAR 2026 highlighted growing momentum behind “immune reset,” an approach adapted from oncology that is quickly gaining traction in autoimmune rheumatic diseases.

  7. What The China Biotech Debate Reveals About U.S. Drug Discovery 8/17/2026

    Peter Kolchinsky and Jason Kelly sparred over China’s biotech rise and what it means for U.S. drug discovery, investment, and strategic control.

  8. Why Ending Rh Disease Requires More Than A Breakthrough (Part 3 of 3) 8/5/2026

    Rh disease has been preventable for decades. Yet babies still die worldwide because access, supply, and infrastructure have not caught up.

  9. Chinese Competition And The Future Of Science: Insights From The U.S. Science Summit 7/24/2026

    At BiotechTV’s U.S. Science Summit, biotech leaders discussed China, AI, scientific storytelling, and what it will take to protect U.S. innovation.

  10. Rethinking The Blueprint For Bone Regeneration: The Next Evolution In Orthobiologics 7/22/2026

    Next-generation orthobiologics could transform spinal fusion by enabling targeted bone regeneration, improving safety, and reducing reliance on traditional grafts and hardware.